Event - 13/11/2024 Networking Evening BW-UK | MEDICA 2024 MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: 08/11/2024, Messe https://www.gesundheitsindustrie-bw.de/en/event/networking-abend-bw-uk-medica-2024
Event - 13/11/2024 Networking Evening BW-UK | MEDICA 2024 MEDICA trade-fair, Baden-Württemberg joint-booth H09, Hall 14, Registration deadline: 08/11/2024, Messe https://www.bio-pro.de/en/events/networking-abend-bw-uk-medica-2024
BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024 Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…https://www.gesundheitsindustrie-bw.de/en/article/press-release/industrial-healthcare-industry-baden-wuerttemberg-gross-value-added-more-19-billion-euros
BIOPRO Baden-Württemberg publishes first results of a new WifOR study - 11/09/2024 Industrial healthcare industry in Baden-Württemberg: gross value added of more than 19 billion euros The industrial healthcare sector (iGW) plays a central role in the economy in Baden-Württemberg. In 2021, the sector generated a direct gross value added of 19.6 billion euros, which corresponds to around a third (32.6%) of the entire regional healthcare industry. Of 96.3%, almost all of the healthcare sectors's exports in the state in 2021 came from the iGW. These are the findings of a new study conducted on behalf of BIOPRO…https://www.bio-pro.de/en/information/press-release/industrial-healthcare-industry-baden-wuerttemberg-gross-value-added-more-19-billion-euros
Event - 01/10/2024 Lunch & Learn: BW-UK Health Industry Procurement - Building Bridges for Better Healthcare Online, Registration deadline: 30/09/2024, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/lunch-und-learn-bw-uk-health-industry-procurement-building-bridges-better-healthcare
Event - 01/10/2024 Lunch & Learn: BW-UK Health Industry Procurement - Building Bridges for Better Healthcare Online, Registration deadline: 30/09/2024, Informationsveranstaltung https://www.bio-pro.de/en/events/lunch-und-learn-bw-uk-health-industry-procurement-building-bridges-better-healthcare
Event - 20/11/2024 DIS&CO Health | Market opportunities in Morocco Online , Registration deadline: 19/11/2024, Informationsveranstaltung https://www.gesundheitsindustrie-bw.de/en/event/dis-und-co-health-marktchancen-marokko
Event - 20/11/2024 DIS&CO Health | Market opportunities in Morocco Online , Registration deadline: 19/11/2024, Informationsveranstaltung https://www.bio-pro.de/en/events/dis-und-co-health-marktchancen-marokko
Press release - 11/07/2024 Presentation of the DKFZ Innovation Award and DKFZ Patient Expert Award The "Friends of the German Cancer Research Center" association supports the DKFZ and aims to help strengthen its position in international competition. With the DKFZ Innovation Award presented at this year's DKFZ annual reception, the association honored Titus Brinker as a researcher whose highly innovative work builds a bridge from research to practical application with commercialization potential.https://www.gesundheitsindustrie-bw.de/en/article/press-release/presentation-dkfz-innovation-award-and-dkfz-patient-expert-award
Save the date - 28/11/2024 Meet & Match - Gender Medicine: Biological insights and healthcare advances Strasbourg (France) | CIARUS, Registration deadline: 27/11/2024, Meet & Match https://www.bio-pro.de/en/events/meet-und-match-gender-medicine-biological-insights-and-healthcare-advances
Save the date - 28/11/2024 Meet & Match - Gender Medicine: Biological insights and healthcare advances Strasbourg (France) | CIARUS, Registration deadline: 27/11/2024, Meet & Match https://www.gesundheitsindustrie-bw.de/en/event/meet-und-match-gender-medicine-biological-insights-and-healthcare-advances
Press release - 05/07/2024 Outstanding ideas – new imaging processes for cancer diagnostics and nanopropellers for ocular gene therapy The summer reception hosted by BioRegio STERN Management GmbH has once again provided a fitting backdrop for the Science2Start award ceremony. Last Thursday, at Tübingen observatory, was the 15th time that scientists and start-up founders were celebrated for outstanding ideas that a panel of experts judged to have special economic potential.https://www.gesundheitsindustrie-bw.de/en/article/press-release/outstanding-ideas-new-imaging-processes-cancer-diagnostics-and-nanopropellers-ocular-gene-therapy
Baden-Württemberg receives the EU Commission's "Regional Innovation Valley" label - 01/07/2024 Customised healthcare for all: BIOPRO is a partner in the EU project PRECISEU The EU research project PRECISEU, which started in June 2024 and will run for five years, aims to connect innovation ecosystems across Europe and advance personalised medicine throughout Europe. BIOPRO Baden-Württemberg is one of 25 partner organisations from 11 European countries that are working on the further development of customised healthcare as part of the research project.https://www.gesundheitsindustrie-bw.de/en/article/press-release/customised-healthcare-all-biopro-partner-eu-project-preciseu
Baden-Württemberg receives the EU Commission's "Regional Innovation Valley" label - 01/07/2024 Customised healthcare for all: BIOPRO is a partner in the EU project PRECISEU The EU research project PRECISEU, which started in June 2024 and will run for five years, aims to connect innovation ecosystems across Europe and advance personalised medicine throughout Europe. BIOPRO Baden-Württemberg is one of 25 partner organisations from 11 European countries that are working on the further development of customised healthcare as part of the research project.https://www.bio-pro.de/en/information/press-release/customised-healthcare-all-biopro-partner-eu-project-preciseu
Press release - 24/06/2024 Trustworthy AI Made in Mannheim How can we use artificial intelligence (AI) to make comprehensible medical decisions? A new project at the University of Mannheim, which has received funding from the Federal Ministry of Education and Research (BMBF), will analyze this question.https://www.gesundheitsindustrie-bw.de/en/article/press-release/trustworthy-ai-made-mannheim
Press release - 21/06/2024 Cyber Valley: World's first ELLIS Institute opens At the finale of the Cyber Valley Days, and Science Minister Petra Olschowski opened the ELLIS Institute Tübingen, heralding the next phase of the AI Innovation Campus. With the world's first ELLIS Institute, Cyber Valley is gaining further radiance. Olschowski also announced at the ceremony that the Karlsruhe Institute of Technology (KIT) is joining the Cyber Valley Community.https://www.gesundheitsindustrie-bw.de/en/article/press-release/cyber-valley-worlds-first-ellis-institute-opens
Press release - 13/06/2024 BioRegio STERN receives 2024 award for best ZIM innovation network BioRegio STERN Management GmbH was today presented with an award at the Innovation Day for SMEs held by Germany’s Federal Ministry for Economic Affairs and Climate Action. Its “biohymed” project was named the year’s best innovation network under the Central Innovation Programme for SMEs (ZIM).https://www.gesundheitsindustrie-bw.de/en/article/press-release/bioregio-stern-receives-2024-award-best-zim-innovation-network
Press release - 07/06/2024 German Research Foundation honors researchers for animal testing alternatives Prof. Dr. Peter Loskill and Dr. Silke Riegger from the 3R Center Tübingen for in-vitro models and animal testing alternatives have been awarded the Ursula M. Händel Animal Welfare Prize 2024. The prize, endowed with 80,000 euros, was awarded to them in Würzburg for the development of organ-on-chip (OoC) systems as an alternative to animal testing.https://www.gesundheitsindustrie-bw.de/en/article/press-release/german-research-foundation-honors-researchers-animal-testing-alternatives
Press release - 05/06/2024 Investing in a fairer future: The Robert Bosch Stiftung celebrates its 60th anniversary he Robert Bosch Stiftung is celebrating its 60th anniversary in 2024. To commemorate this, the Foundation is holding an anniversary celebration today at its headquarters in Stuttgart. Among the guests are partners from the Foundation's charitable work as well as representatives from politics, business, and society, including members of the Bosch family and company.https://www.gesundheitsindustrie-bw.de/en/article/press-release/investing-fairer-future-robert-bosch-stiftung-celebrates-its-60th-anniversary
Press release - 23/05/2024 "They heal wounds, allow bones to grow and calm inflammation" MWK funds cell therapy research into mesenchymal stromal cells with 600,000 euros The Baden-Württemberg Ministry of Science, Research and Arts (MWK) is supporting medical researchers at Ulm University with start-up funding totalling 600,000 euros. The aim is to establish an EU consortium for the broad therapeutic use of mesenchymal stromal cells. The funding is being awarded as part of the "BEGIN - Participation in major European projects and initiatives" programme.https://www.gesundheitsindustrie-bw.de/en/article/press-release/they-heal-wounds-allow-bones-grow-and-calm-inflammation-mwk-funds-cell-therapy-research-mesenchymal-stromal-cells-600000-euros
Press release - 20/05/2024 seleon GmbH becomes part of the aesco solutions group On May 17, 2024, aesco solutions, a leading group for production and development services (CDMO) for medical device companies, and D11Z. Ventures GmbH & Co. KG (formerly Zukunftsfonds Heilbronn) announce the closing of the acquisition of seleon GmbH.https://www.gesundheitsindustrie-bw.de/en/article/press-release/seleon-gmbh-becomes-part-aesco-solutions-group
Press release - 15/05/2024 Tumour tissue on a chip: new possibilities for cell therapies and personalized medicine How do tumors react to a certain therapeutic approach? Knowing this before the start of a therapy would be of enormous value for people suffering from cancer as well as for the doctors treating them. Researchers have now made this very observation possible for the CAR-T cell therapy. This allows us to individually investigate how exactly these tumor cells react to the planned therapy.https://www.gesundheitsindustrie-bw.de/en/article/press-release/tumour-tissue-chip-new-possibilities-cell-therapies-and-personalized-medicine
Press release - 13/05/2024 Detecting respiratory infections: simply blow for diagnosis Professor Claudia Denkinger from Heidelberg University's Faculty of Medicine is leading the international collaborative project "BreathForDiagnosis". Researchers from Germany, Italy, South Africa and Romania are working with an industrial partner from Switzerland to develop user-friendly breath tests for the rapid diagnosis of respiratory infections such as tuberculosis.https://www.gesundheitsindustrie-bw.de/en/article/press-release/detecting-respiratory-infections-simply-blow-diagnosis
Press release - 24/04/2024 Strengthening the healthcare sector in the state: BIOPRO Baden-Württemberg networks itself strategically at a European level BIOPRO has been supporting Baden-Württemberg as a healthcare location for many years and provides important incentives for its further development. The state company has been a member of the Council of European Bioregions (CEBR) network since April 2024. Within the CEBR, BIOPRO aims to network with European cooperation partners in order to provide even better support for the innovative capacity of the healthcare industry in Baden-Württemberg.https://www.bio-pro.de/en/information/press-release/strengthening-healthcare-sector-state-biopro-baden-wuerttemberg-networks-itself-strategically-european-level
Press release - 18/04/2024 Collagen: Researchers at the NMI decipher how it works in medical treatment Collagen has been used in ophthalmology since the 1990s, particularly in the treatment of corneal defects. However, why and how this technique works was only known in theory. Researchers at the NMI Natural and Medical Sciences Institute in Reutlingen led by Lu Fan have found the necessary evidence and can now reliably explain how this technique works.https://www.gesundheitsindustrie-bw.de/en/article/press-release/collagen-researchers-nmi-decipher-how-it-works-medical-treatment